CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-90
SponsorJason Sperry
About this trial
The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.
Eligibility criteria
Qualifiers
None
Disqualifiers
Wearing NO CAVALIER opt-out bracelet
Age > 90 or < 18 years of age
Isolated fall from standing injury mechanism
Known prisoner
Trial design
Treatments tested in this trial
- Calcium Gluconate
- Vasopressin
- saline placebo
Treatment groups
1,050 Participants
are divided into 4 treatment groupsSponsors and collaborators
Jason Sperry
Lead sponsor
University of Pittsburgh
Sponsor institution
United States Department of Defense
Collaborator
Source ClinicalTrials.gov